Found: 8
Select item for more details and to access through your institution.
A stochastic model for immunotherapy of cancer.
- Published in:
- Scientific Reports, 2016, p. 24169, doi. 10.1038/srep24169
- By:
- Publication type:
- Article
Author Correction: Neoadjuvant durvalumab plus radiation versus durvalumab alone in stages I–III non-small cell lung cancer: survival outcomes and molecular correlates of a randomized phase II trial.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
Neoadjuvant durvalumab plus radiation versus durvalumab alone in stages I–III non-small cell lung cancer: survival outcomes and molecular correlates of a randomized phase II trial.
- Published in:
- Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-44195-x
- By:
- Publication type:
- Article
Tumor cell intrinsic Toll‐like receptor 4 signaling promotes melanoma progression and metastatic dissemination.
- Published in:
- International Journal of Cancer, 2022, v. 150, n. 1, p. 142, doi. 10.1002/ijc.33804
- By:
- Publication type:
- Article
Ultraviolet-radiation-induced inflammation promotes angiotropism and metastasis in melanoma.
- Published in:
- Nature, 2014, v. 507, n. 7490, p. 109, doi. 10.1038/nature13111
- By:
- Publication type:
- Article
Melanomas resist T-cell therapy through inflammation-induced reversible dedifferentiation.
- Published in:
- Nature, 2012, v. 490, n. 7420, p. 412, doi. 10.1038/nature11538
- By:
- Publication type:
- Article
The myeloid cell type I IFN system promotes antitumor immunity over pro‐tumoral inflammation in cancer T‐cell therapy.
- Published in:
- Clinical & Translational Immunology, 2021, v. 10, n. 4, p. 1, doi. 10.1002/cti2.1276
- By:
- Publication type:
- Article
Suppressing PD-L1 Expression via AURKA Kinase Inhibition Enhances Natural Killer Cell-Mediated Cytotoxicity against Glioblastoma.
- Published in:
- Cells (2073-4409), 2024, v. 13, n. 13, p. 1155, doi. 10.3390/cells13131155
- By:
- Publication type:
- Article